Related references
Note: Only part of the references are listed.Glucose conjugated platinum(II) complex: Antitumor superiority to oxaliplatin, combination effect and mechanism of action
Hong Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy
Xiaopeng Han et al.
MEDICINAL RESEARCH REVIEWS (2015)
Conjugation of vitamin E analog α-TOS to Pt(IV) complexes for dual-targeting anticancer therapy
Kogularamanan Suntharalingam et al.
CHEMICAL COMMUNICATIONS (2014)
The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
Qinqin Cheng et al.
CHEMICAL COMMUNICATIONS (2014)
Cover Picture: Photoinduced Reduction of PtIVwithin an Anti-Proliferative PtIV-Texaphyrin Conjugate (Chem. Eur. J. 29/2014)
Grégory Thiabaud et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
Yao-Rong Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties
Pengxing Liu et al.
CHEMICAL COMMUNICATIONS (2013)
Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes
Giuseppe Ermondi et al.
DALTON TRANSACTIONS (2013)
An Updated View of Cisplatin Transport
Fabio Arnesano et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2013)
Pt(IV) complexes as prodrugs for cisplatin
Yi Shi et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Platinum(II) compounds bearing bone-targeting group: synthesis, crystal structure and antitumor activity
Zuqin Xue et al.
CHEMICAL COMMUNICATIONS (2010)
A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity
Darren Griffith et al.
CHEMICAL COMMUNICATIONS (2009)
The mechanism of action of platinum anticancer agents-what do we really know about it?
Dan Gibson
DALTON TRANSACTIONS (2009)
Current status and future prospects for satraplatin, an oral platinum analogue
Hak Choy et al.
CLINICAL CANCER RESEARCH (2008)
Carbohydrate-Metal Complexes and their Potential as Anticancer Agents
Christian G. Hartinger et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy
Yu-Ling Leu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Basis for design and development of Platinum(IV) anticancer complexes
Matthew D. Hall et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Direct cellular responses to platinum-induced DNA damage
Yongwon Jung et al.
CHEMICAL REVIEWS (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Toxicity of platinum compounds
JT Hartmann et al.
EXPERT OPINION ON PHARMACOTHERAPY (2003)
Platinum(IV) antitumour compounds: their bioinorganic chemistry
MD Hall et al.
COORDINATION CHEMISTRY REVIEWS (2002)
Share Paper
